Novel cellular senescence-related risk model identified as the prognostic biomarkers for lung squamous cell carcinoma.
Frontiers in oncology(2022)
摘要
We discovered a new LUSC classification based on six cellular senescence-related genes, which will aid in identifying patients who will benefit from anti-PD-1 treatment. Targeting senescence-related genes appears to be another option for improving clinical therapy for LUSC.
更多查看译文
关键词
immune microenvironment,immunotherapy,lung squamous cell carcinoma,overall survival,senescence
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要